Circular RNA: Transforming a Promising Technology into Cutting-Edge Therapeutics
Time: 2:00 pm
day: Conference Day Two
Details:
• Introduction to RiboX Therapeutics, a globally operated biotech company pioneering fully engineered circular RNA (circRNA) therapeutics. RiboX’s proprietary therapeutic platforms include a plug-and-play circular RNA platform, an ionizable lipid platform and unique assets in active LNP targeting
• Preclinical proof of concept study demonstrating the advantages of circRNA as a therapeutic modality
• Brief overview and development status of RiboX’s clinical stage circRNA therapeutic, marking the first circRNA to enter clinical development
New Data
New Company
